Slingerland JM - Search Results

1

p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies.

Wander SA, Zhao D, Slingerland JM. Wander SA, et al. Among authors: slingerland jm. Clin Cancer Res. 2011 Jan 1;17(1):12-8. doi: 10.1158/1078-0432.CCR-10-0752. Epub 2010 Oct 21. Clin Cancer Res. 2011. PMID: 20966355 Free PMC article. Review.

2

Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma.

Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH, Slingerland JM. Tsihlias J, et al. Among authors: slingerland jm. Cancer Res. 1998 Feb 1;58(3):542-8. Cancer Res. 1998. PMID: 9458103

3

Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras.

Catzavelos C, Tsao MS, DeBoer G, Bhattacharya N, Shepherd FA, Slingerland JM. Catzavelos C, et al. Among authors: slingerland jm. Cancer Res. 1999 Feb 1;59(3):684-8. Cancer Res. 1999. PMID: 9973218

4

Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer.

Alkarain A, Slingerland J. Alkarain A, et al. Breast Cancer Res. 2004;6(1):13-21. doi: 10.1186/bcr722. Epub 2003 Oct 21. Breast Cancer Res. 2004. PMID: 14680481 Free PMC article. Review.

5

The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer.

Chu I, Blackwell K, Chen S, Slingerland J. Chu I, et al. Cancer Res. 2005 Jan 1;65(1):18-25. Cancer Res. 2005. PMID: 15665275

6

p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2.

Chu I, Sun J, Arnaout A, Kahn H, Hanna W, Narod S, Sun P, Tan CK, Hengst L, Slingerland J. Chu I, et al. Cell. 2007 Jan 26;128(2):281-94. doi: 10.1016/j.cell.2006.11.049. Cell. 2007. PMID: 17254967 Free PMC article.

7

The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.

Chu IM, Hengst L, Slingerland JM. Chu IM, et al. Among authors: slingerland jm. Nat Rev Cancer. 2008 Apr;8(4):253-67. doi: 10.1038/nrc2347. Nat Rev Cancer. 2008. PMID: 18354415 Review.

8

Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4.

Larrea MD, Liang J, Da Silva T, Hong F, Shao SH, Han K, Dumont D, Slingerland JM. Larrea MD, et al. Among authors: slingerland jm. Mol Cell Biol. 2008 Oct;28(20):6462-72. doi: 10.1128/MCB.02300-07. Epub 2008 Aug 18. Mol Cell Biol. 2008. PMID: 18710949 Free PMC article.

9

Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors.

Chen Y, Guggisberg N, Jorda M, Gonzalez-Angulo A, Hennessy B, Mills GB, Tan CK, Slingerland JM. Chen Y, et al. Among authors: slingerland jm. Clin Cancer Res. 2009 May 15;15(10):3396-405. doi: 10.1158/1078-0432.CCR-08-3127. Clin Cancer Res. 2009. PMID: 19451593

10

RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility.

Larrea MD, Hong F, Wander SA, da Silva TG, Helfman D, Lannigan D, Smith JA, Slingerland JM. Larrea MD, et al. Among authors: slingerland jm. Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9268-73. doi: 10.1073/pnas.0805057106. Epub 2009 May 22. Proc Natl Acad Sci U S A. 2009. PMID: 19470470 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters